226 related articles for article (PubMed ID: 3659256)
21. Metastasis to the thyroid diagnosed by fine-needle aspiration biopsy.
Kim TY; Kim WB; Gong G; Hong SJ; Shong YK
Clin Endocrinol (Oxf); 2005 Feb; 62(2):236-41. PubMed ID: 15670202
[TBL] [Abstract][Full Text] [Related]
22. Surgical and ablative treatment for metastatic adenocarcinoma to the liver from unknown primary tumor.
Hawksworth J; Geisinger K; Zagoria R; Kavanagh P; Howerton R; Levine EA; Shen P
Am Surg; 2004 Jun; 70(6):512-7. PubMed ID: 15212405
[TBL] [Abstract][Full Text] [Related]
23. Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.
Karam AK; Stempel M; Barakat RR; Morrow M; Gemignani ML
Gynecol Oncol; 2009 Mar; 112(3):490-5. PubMed ID: 19101713
[TBL] [Abstract][Full Text] [Related]
24. Surgical and nonsurgical management of primary and metastatic liver tumors.
Zibari GB; Riche A; Zizzi HC; McMillan RW; Aultman DF; Boykin KN; Gonzalez E; Nandy I; Dies DF; Gholson CF; Holcombe RF; McDonald JC
Am Surg; 1998 Mar; 64(3):211-20; discussion 220-1. PubMed ID: 9520809
[TBL] [Abstract][Full Text] [Related]
25. Cancer of unknown primary site.
Schlag PM; Hünerbein M
Ann Chir Gynaecol; 1994; 83(1):8-12. PubMed ID: 8053645
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis and treatment of unknown primary tumors].
Dodion P; De Valeriola D
Bull Cancer; 1989; 76(9):939-46. PubMed ID: 2695183
[TBL] [Abstract][Full Text] [Related]
28. Factors affecting the prognosis of patients with carcinoma of the thyroid.
Ito J; Noguchi S; Murakami N; Noguchi A
Surg Gynecol Obstet; 1980 Apr; 150(4):539-44. PubMed ID: 7361243
[TBL] [Abstract][Full Text] [Related]
29. [Metastasizing adenocarcinoma from an unknown primary tumor].
von Heyden HW; Hansen D; Kaboth U; Nagel GA; Hoffmann H; Schneider B
Dtsch Med Wochenschr; 1984 Jan; 109(1):15-9. PubMed ID: 6692759
[TBL] [Abstract][Full Text] [Related]
30. Osseous adenocarcinoma of unknown primary site: study of survival and prognostic factors.
Saengnipanthkul S; Jirarattanaphochai K; Laupattarakasem W; Laopaiboon M; Kowsuwon W; Rojviroj S
J Med Assoc Thai; 1992 Sep; 75(9):502-7. PubMed ID: 1304019
[TBL] [Abstract][Full Text] [Related]
31. A clinical study of adenocarcinoma of unknown primary site in Hong Kong.
Teo P; Shiu W; Tsao SY
Singapore Med J; 1989 Dec; 30(6):571-3. PubMed ID: 2635404
[TBL] [Abstract][Full Text] [Related]
32. Treatment for patients with unknown primary cancer and favorable prognostic factors.
Hainsworth JD; Fizazi K
Semin Oncol; 2009 Feb; 36(1):44-51. PubMed ID: 19179187
[TBL] [Abstract][Full Text] [Related]
33. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
[TBL] [Abstract][Full Text] [Related]
34. Management of patients with brain metastases of unknown origin.
Debevec M
Neoplasma; 1990; 37(5):601-6. PubMed ID: 2234220
[TBL] [Abstract][Full Text] [Related]
35. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Cheng L; Bostwick DG
J Urol; 1999 Apr; 161(4):1233-7. PubMed ID: 10081876
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
37. Treatment strategy for patients with middle and lower third bile duct cancer.
Todoroki T; Kawamoto T; Koike N; Fukao K; Shoda J; Takahashi H
Br J Surg; 2001 Mar; 88(3):364-70. PubMed ID: 11260100
[TBL] [Abstract][Full Text] [Related]
38. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
[TBL] [Abstract][Full Text] [Related]
39. Treatment of patients with cancer of unknown primary site.
Hainsworth JD; Greco FA
Important Adv Oncol; 1991; ():173-90. PubMed ID: 1869276
[TBL] [Abstract][Full Text] [Related]
40. HER-2 status in primary oesophageal cancer, lymph nodes and distant metastases.
Schoppmann SF; Jesch B; Zacherl J; Wrba F; Hejna M; Maresch J; Langer FB; Riegler MF; Pluschnig U; Birner P
Br J Surg; 2011 Oct; 98(10):1408-13. PubMed ID: 21618213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
